Peer Review History

Original SubmissionAugust 5, 2023
Decision Letter - Johannes Reisert, Editor

PONE-D-23-24390Mapping of the human intranasal mucosal thermal sensitivity: A clinical study on thermal threshold and trigeminal receptorsPLOS ONE

Dear Dr. Weise,

Thank you for submitting your manuscript to PLOS ONE. Please revise your current manuscript by including the figure legends and upload a new version with the figures also. Please double check that, once uploaded, the manuscript is complete.

Please submit your revised manuscript by Dec 28 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Johannes Reisert

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following financial disclosure: 

"The Article Processing Charges (APC) were funded by the joint publication funds of the TU Dresden, including Carl Gustav Carus Faculty of Medicine, and the SLUB Dresden as well as the Open Access Publication Funding of the DFG.

This project has received funding from the European Union's Horizon 2020 [research and innovation programme] under grant agreement No. 964529 (ROSE = Restoring Odorant Detection and Recognition in Smell Deficits)."

  

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

6. Please include a separate caption for each figure in your manuscript.

7. Please ensure that you refer to Figure 4 in your text as, if accepted, production will need this reference to link the reader to the figure.

8. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 5 in your text; if accepted, production will need this reference to link the reader to the Table.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Reviewer,

I appreciate the time and effort you and the reviewers have dedicated to evaluating my manuscript. I sincerely apologize for the formatting errors present in the submitted manuscript titled "Mapping of the human intranasal mucosal thermal sensitivity: A clinical stud on thermal threshold and trigeminal receptors". Unfortunately, there were unintended issues that led to error messages and the absence of figure captions.I have carefully considered the points raised and would like to provide a detailed response to each.

1. Change of Figure Legends: The reviewers suggested a change in the figure legends. I have revisited the legends and made the necessary adjustments to ensure clarity and accuracy.

2. Upload of a New Version with Figures: I have carefully reviewed all the figures in the manuscript and have made the required modifications.

I would like to express my gratitude for the constructive feedback provided by the reviewers. Their insights have been invaluable in enhancing the quality of the manuscript.

Thank you for your time and consideration. I look forward to hearing your thoughts on the revised manuscript.

Best regards,

Susanne Weise

Attachments
Attachment
Submitted filename: Letter_23-12-6.docx
Decision Letter - Johannes Reisert, Editor

PONE-D-23-24390R1Hot topic: Mapping of the human intranasal mucosal thermal sensitivity: A clinical study on thermal threshold and trigeminal receptorsPLOS ONE

Dear Dr. Weise,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Johannes Reisert

Academic Editor

PLOS ONE

Additional Editor Comments:

Please address all the comments made by the reviewer by elaborating in particular on your experimental procedures in regards to thermal stimulation, clarify mechanical vs thermal stimulation and your positive controls for PCR experiments

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this Manuscript, Weise et al. mapped the thermal sensitivity of human nasal mucosa. They tested for thermal sensitivity different locations in the nose of 20 healthy subjects and found that thermal threshold was different depending from the site of where the measures were taken. They also found several correlations between thermal sensitivity and olfactory function, ratings of trigeminal stimuli (AmmoLa® stick), a questionnaire regarding trigeminal function, nasal patency, and CO2 threshold. In addition, they attempt to identify molecular correlates to their finding by investigating the expression of TRP channels by performing qPCR from nasal swabs taken from different locations of human nasal mucosa.

The manuscript is interesting and present a complete characterization of human olfactory and trigeminal abilities.

I do have some concerns though:

1. It is not clear to me what could be the physiological meaning of testing thermal sensitivity in the nose. The authors might want to better explain the rationale of the study.

2. Since the most relevant and innovative aspect of the paper is indeed the nasal thermal stimulation, the authors should better explain the stimulation protocol. Indeed, it is not clear to me how the stimulation worked. For example: Could the authors apply different temperatures (from figure 2 it seems that this is the case but the discussion section lines 438 to 440 “thermal stimulation at various temperatures and for extended stimulating intervals could provide a more comprehensive characterization of perception” confused me)? In addition, how are duration and intensity related? I could not understand it from the methods section and figure 2 do not help in clarifying this issue.

3. A somehow related topic is the consideration of the thermal stimulation as mechanical one. This is reported in the discussion (line 426-431). Unless better explained I would consider thermal stimulation as different from mechanical. TRP channels are rather poorly sensitive to mechanical stimulation unless it is referred to a change in cellular volume. Do the authors mean that during heating the electrode went through thermal expansion? Would then be the expansion the mechanical stimulus? It is rather confusing; I think the issue could be solved by a clearer explanation of the set-up and protocol in the methods.

4. I think the qPCR lack of positive controls, since the authors state that often they failed to find TRPA1 and TRPM8. How could they be sure that the qPCR run under optimal conditions and with the right primers?

5. The Discussion section is too long, shortening may help to make it clearer.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Author´s reply to the comments of the reviewer

The authors thank the referees for the constructive criticism to which we would like to respond as follows:

1. It is not clear to me what could be the physiological meaning of testing thermal sensitivity in the nose. The authors might want to better explain the rationale of the study.

Answer:

The authors thank the reviewer for the comments. The olfactory and trigeminal system are closely interlinked in terms of anatomy and function. Trigeminal activation can be induced by thermal, mechanical, or chemosensory stimulation. While numerous studies have concentrated on mechanical and chemosensory trigeminal stimulation, there exists a gap in information concerning thermal trigeminal stimulation. This study seeks to fill this void by shedding light on the functional and physiological aspects of thermal stimulation within the nasal cavity.

In this study, the thermal stimulation in the human nasal cavity was conducted for the first time. The stimulus threshold was investigated at various points within the nose. Additionally, the perception of suprathreshold stimulation was evaluated. Furthermore, nasal swabs were taken to examine receptor expression for the perception of thermal stimuli at different points within the nasal cavity.

The knowledge gained is important from a scientific perspective due to the inaugural exploration of thermal stimulation in the nasal cavity. Furthermore, these findings might be applied in the future for therapeutic trigeminal stimulation within the nose, for trigeminal dysfunction or olfactory dysfunction due to the close interlink between both systems.

2. Since the most relevant and innovative aspect of the paper is indeed the nasal thermal stimulation, the authors should better explain the stimulation protocol. Indeed, it is not clear to me how the stimulation worked. For example: Could the authors apply different temperatures (from figure 2 it seems that this is the case but the discussion section lines 438 to 440 “thermal stimulation at various temperatures and for extended stimulating intervals could provide a more comprehensive characterization of perception” confused me)? In addition, how are duration and intensity related? I could not understand it from the methods section and figure 2 do not help in clarifying this issue.

Answer:

The authors thank the reviewer for these comments. In response to the comment, the Methods section has been revised to clearly elucidate the procedure for thermal stimulation, see line 163-207.

3. A somehow related topic is the consideration of the thermal stimulation as mechanical one. This is reported in the discussion (line 426-431). Unless better explained I would consider thermal stimulation as different from mechanical. TRP channels are rather poorly sensitive to mechanical stimulation unless it is referred to a change in cellular volume. Do the authors mean that during heating the electrode went through thermal expansion? Would then be the expansion the mechanical stimulus? It is rather confusing; I think the issue could be solved by a clearer explanation of the set-up and protocol in the methods.

Answer:

The authors thank the reviewer for these comments. The reviewers are absolutely correct in pointing out the distinction between thermal and mechanical stimulation in this study. In the present study, the thermal stimulation was administered via an electrode that needs to be placed on the tissue. By positioning the electrode on the intranasal mucosa, discrete irritation can occur, which might result in a discrete mechanical stimulus. However, the placement of the electrode was done under endoscopic control in order to decrease the potential mechanical stimulation. We did not consider a thermal expansion due to the short exposure to heat. The potential mechanical irritation mentioned in the discussion (line 430) refers solely to the process of electrode placement on the tissue. The section methodology was revised to elucidate this aspect (see line 186-188).

This study is the first one on thermal intranasal stimulation, emphasizing the significance of the study.

4. I think the qPCR lack of positive controls, since the authors state that often they failed to find TRPA1 and TRPM8. How could they be sure that the qPCR run under optimal conditions and with the right primers?

Answer:

The authors thank the reviewer for these comments. This study exclusively utilized assays validated by the manufacturer, which were cultivated under the conditions specified by the manufacturer. A positive control was conducted with the cell line LNCaP.

5. The Discussion section is too long, shortening may help to make it clearer.

Answer:

The authors thank the reviewer for these comments. The authors followed the reviewer’s suggestion, the section discussion was shortened and thoroughly revised (line 389-536).

Attachments
Attachment
Submitted filename: point-by-point reply_reviewer_2024-03-12.doc
Decision Letter - Johannes Reisert, Editor

Hot topic: Mapping of the human intranasal mucosal thermal sensitivity: A clinical study on thermal threshold and trigeminal receptors

PONE-D-23-24390R2

Dear Dr. Weise,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Johannes Reisert

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors adequately addressed my comments. In particular, the method of thermal stimulation is now better described.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Formally Accepted
Acceptance Letter - Johannes Reisert, Editor

PONE-D-23-24390R2

PLOS ONE

Dear Dr. Weise,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Johannes Reisert

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .